FDA Inspection 1187343 — Neil Martin
The FDA completed an inspection of Neil Martin on Nov 2, 2022 in New Paris, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 2, 2022
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- New Paris, IN (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 13509 | FDCA 402(a)(4) | Individual identity of animal(s) |
| 13521 | 21 CFR 530.41(a) | Drugs prohibited for extralabel use in food-producing animal(s) |
| 1457 | FDCA 402(a)(4) | Feeding waste milk/colostrum |
| 22694 | FDCA 402(a)(2)(C)(ii) | Introduction/delivery into IS - illegal drug residue |
| 4182 | FDCA 501(a)(5) | ELDU without veterinary client-patient relationship |
| 4185 | FDCA 402(a)(4) | Record keeping |
| 7001 | FDCA 402(a)(4) | Drug inventory (control of drugs on premises) |